Abstract
The last decade has been characterized by the development and approval of pretomanid and delamanid, which are nitroimidazole based drugs for multidrug -resistant tuberculosis. This attracted renewed attention to the nitroheterocyclic scaffolds as a source of safe and efficient antimicrobial agents. While the primary focus is still on nitrofurans and nitroimidazoles, well known as bioreducible prodrugs, a number of studies have been published on other 5-membered nitroheteroaromatic compounds. The latter not only show promising antimicrobial activity but also demonstrate modes of action different from the conventional reductive activation of the nitro group. Considering the potential of these efforts to impact the continuing race against drug-resistant pathogens, herein we review non-furan/imidazole-based 5-membered nitroheteroaromatics investigated as antimicrobial agents in 2010-2020.
Keywords: Nitroaromatic heterocycles, nitrothiophenes, nitropyrroles, nitroisoxazoles, nitro-1, 2, 4-triazoles, nitrothiazoles, antimicrobial agents, drug-resistant pathogens, microbial enzymes.
Current Medicinal Chemistry
Title:Antimicrobial Activity of 5-membered Nitroheteroaromatic Compounds beyond Nitrofurans and Nitroimidazoles: Recent Progress
Volume: 28 Issue: 29
Author(s): Stanislav Kalinin, Tatiana Vedekhina, Polina Paramonova and Mikhail Krasavin*
Affiliation:
- Institute of Chemistry, St. Petersburg State University, St. Petersburg,Russian Federation
Keywords: Nitroaromatic heterocycles, nitrothiophenes, nitropyrroles, nitroisoxazoles, nitro-1, 2, 4-triazoles, nitrothiazoles, antimicrobial agents, drug-resistant pathogens, microbial enzymes.
Abstract: The last decade has been characterized by the development and approval of pretomanid and delamanid, which are nitroimidazole based drugs for multidrug -resistant tuberculosis. This attracted renewed attention to the nitroheterocyclic scaffolds as a source of safe and efficient antimicrobial agents. While the primary focus is still on nitrofurans and nitroimidazoles, well known as bioreducible prodrugs, a number of studies have been published on other 5-membered nitroheteroaromatic compounds. The latter not only show promising antimicrobial activity but also demonstrate modes of action different from the conventional reductive activation of the nitro group. Considering the potential of these efforts to impact the continuing race against drug-resistant pathogens, herein we review non-furan/imidazole-based 5-membered nitroheteroaromatics investigated as antimicrobial agents in 2010-2020.
Export Options
About this article
Cite this article as:
Kalinin Stanislav , Vedekhina Tatiana, Paramonova Polina and Krasavin Mikhail *, Antimicrobial Activity of 5-membered Nitroheteroaromatic Compounds beyond Nitrofurans and Nitroimidazoles: Recent Progress, Current Medicinal Chemistry 2021; 28 (29) . https://dx.doi.org/10.2174/0929867328666210216114838
DOI https://dx.doi.org/10.2174/0929867328666210216114838 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Progress in Biological Activities of Indole and Indole Alkaloids
Mini-Reviews in Medicinal Chemistry Adjunctive Immunotherapy of Mycobacterial Infections
Current Pharmaceutical Design New Heterocyclic Hydrazones in the Search for Antitubercular Agents: Synthesis and In Vitro Evaluations
Letters in Drug Design & Discovery Advanced in Silico Methods for the Development of Anti- Leishmaniasis and Anti-Trypanosomiasis Agents
Current Medicinal Chemistry The Unique Features of Pediatric HIV-1 in Sub-Saharan Africa
Current HIV Research The Synthetic and Biological Attributes of Pyrazole Derivatives: A Review
Mini-Reviews in Medicinal Chemistry Targeting Intracellular Targets
Current Drug Delivery Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment
Current Cancer Drug Targets The Human Trypanolytic Factor: A Drug Shaped Naturally
Infectious Disorders - Drug Targets Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design Occupational Exposure and Respiratory Tract Infections –At Risk Workers in the International Context
Current Respiratory Medicine Reviews Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Phytochemicals, Medicinal and Food Applications of Shatavari (Asparagus racemosus): An Updated Review
The Natural Products Journal SV40 and HIV Sequences in the Cerebrospinal Fluid of a Patient with AIDS Dementia Complex
Current HIV Research Nitroimidazoles, Quinolones and Oxazolidinones as Fluorine Bearing Antitubercular Clinical Candidates
Mini-Reviews in Medicinal Chemistry 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy Editorial (Thematic Issue: The Thoracic Space: An Amazing Pandora’s Box!)
Current Respiratory Medicine Reviews Arylurea Derivatives: A Class of Potential Cancer Targeting Agents
Current Topics in Medicinal Chemistry Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles
Current Pharmaceutical Design